Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.
about
Pneumococcal vaccination rates in adults in Germany: an analysis of statutory health insurance data on more than 850,000 individualsEffect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants.Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992-2008).Serotype replacement in disease after pneumococcal vaccinationEffects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands.Serotypes and genotypes of invasive Streptococcus pneumoniae before and after PCV10 implementation in southern BrazilMacrolide resistance determinants among Streptococcus pneumoniae isolates from carriers in Central GreeceEpidemiology of serotype 19A isolates from invasive pneumococcal disease in German childrenClonal expansion within pneumococcal serotype 6C after use of seven-valent vaccine.Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?Invasive pneumococcal diseases in children and adolescents--a single centre experienceIncrease of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era.Vaccination recommendations for Germany.Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany.Pneumococcal serotypes in children in 4 European countriesEffectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in GermanyPotential cost-effectiveness and benefit-cost ratios of adult pneumococcal vaccination in GermanyEffect of 10-valent pneumococcal vaccine on pneumonia among children, Brazil.Conjugation of polysaccharide 6B from Streptococcus pneumoniae with pneumococcal surface protein A: PspA conformation and its effect on the immune responseVaccination timing of low-birth-weight infants in rural Ghana: a population-based, prospective cohort study.Outpatient Antibiotic Prescription.Why do we need a systematic review of pneumococcal conjugate vaccine dosing schedules?Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children.Global prevailing and emerging pediatric pneumococcal serotypes.Observed differences in invasive pneumococcal disease epidemiology after routine infant vaccination.The development of 13-valent pneumococcal conjugate vaccine and its possible use in adults.Epidemiologic and clinical implications of second-generation pneumococcal conjugate vaccines.The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review.Cost effectiveness of the new pneumococcal vaccines: a systematic review of European studies.Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany.Pneumococcal Conjugate Vaccine--Equally Effective for Everyone?27th Annual Meeting of the European Society for Pediatric Infectious Disease.Clinical characteristics of children with lower respiratory tract infections are dependent on the carriage of specific pathogens in the nasopharynx.
P2860
Q30702357-9EBD586E-C872-43E6-848C-D8406F1CBEBCQ33525194-12472804-3184-4455-9403-486F5E31F9D1Q34021871-347D0B15-A0FB-4F94-AFF2-3CDFB4A0CC12Q34178363-4870EBCF-6435-4F66-832B-0F545720D19FQ34194058-BA43BB2A-4714-4D74-8FF2-A94FC33D47F3Q34428419-F698DCF2-7E6A-4987-BF11-70EF9322131FQ34443354-81B947EE-20C2-4A4D-B838-12853AC03A5CQ34577705-CB02A6FD-C65E-4AA2-9F2A-C990FA19129FQ34749756-DCE1B96D-BC97-4ABD-AB04-F5BE7B887BD3Q34798448-49B3ED33-7DCC-4632-9153-4F540ECD5350Q35119564-0863406E-8269-44B7-B5B7-B7E3759CC7F4Q35583895-70ADD11F-DBA0-4D6F-85F6-EE48DB496C91Q35591138-FC6D815A-71B5-4A5B-9690-3B69F267F994Q35679787-603DA388-AA24-46E6-80A1-07D87094ABDCQ35806522-FDA86A9D-F074-46A3-A774-8E477D7F020AQ36104219-B2356E81-71D2-4104-A8F5-6BC06AF409D0Q36295092-1E65C2FC-3C8B-463C-BC42-EC47452691FCQ36825163-C7A28AB3-82CF-4663-A0F8-3CA98EC95EE6Q36911270-C99E148A-C512-40FC-B600-C265BB6FDB8DQ36959974-DA27958E-D53B-431F-A4CB-DE5264D46A31Q37097422-4DEE19CE-D318-41FE-89A5-816799EA4D29Q37613609-68BC2283-5941-45DD-95CE-3EE063EF5514Q37621064-129E1CF1-DF93-49AF-823C-49BB19501AA6Q37821484-4B104A39-7CB6-4D60-AAEB-A613C2908A01Q37844538-EDD2B793-EDEB-4B1B-BDA3-0FA03DD40C46Q37954709-3DB74951-5F69-419F-99C4-CED7100E588AQ38079159-0AA238FF-C9BB-4DB1-AA00-7F1C562DD0D7Q38080478-3AC22AD2-8437-4992-9439-22056FC32DDBQ38167294-1EE48D39-D26C-4EFE-BFE9-D09442CDA30FQ39976528-92C674C2-F435-4C7A-9259-81258C8B7ED6Q42941513-0CA27A84-D68C-46DD-976F-EA4EF850C477Q43777687-341AABB6-59A9-428A-BE80-569AFB44649EQ47317895-49973A36-A579-46E2-A880-8D9F4865C719
P2860
Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Reduction in the incidence of ...... conjugate vaccine in Germany.
@en
Reduction in the incidence of ...... conjugate vaccine in Germany.
@nl
type
label
Reduction in the incidence of ...... conjugate vaccine in Germany.
@en
Reduction in the incidence of ...... conjugate vaccine in Germany.
@nl
prefLabel
Reduction in the incidence of ...... conjugate vaccine in Germany.
@en
Reduction in the incidence of ...... conjugate vaccine in Germany.
@nl
P2093
P1433
P1476
Reduction in the incidence of ...... conjugate vaccine in Germany.
@en
P2093
Anette Siedler
Florian Burckhardt
Ralf René Reinert
Rüdiger von Kries
Simon Rückinger
P304
P356
10.1016/J.VACCINE.2009.04.057
P407
P577
2009-05-09T00:00:00Z